News
CELUW
0.0400
+0.25%
0.0001
Weekly Report: what happened at CELUW last week (0407-0411)?
Weekly Report · 5d ago
Celularity Welcomes CMS Action on Medicare Local Coverage Determination for Skin Substitutes Products
Barchart · 5d ago
Weekly Report: what happened at CELUW last week (0331-0404)?
Weekly Report · 04/07 10:46
CELULARITY FILES FOR NON-TIMLEY 10-K - SEC FILING
Reuters · 03/31 21:46
CELULARITY: SEES NET REVENUES FOR YEAR ENDED DEC 31, 2024 OF $54.2 MLN
Reuters · 03/31 21:46
Weekly Report: what happened at CELUW last week (0324-0328)?
Weekly Report · 03/31 10:56
Weekly Report: what happened at CELUW last week (0317-0321)?
Weekly Report · 03/24 10:46
CELULARITY INC - EXTENDS NOTE MATURITY DATE TO MAY 12, 2025 - SEC FILING
Reuters · 03/21 20:35
Weekly Report: what happened at CELUW last week (0310-0314)?
Weekly Report · 03/17 10:54
Weekly Report: what happened at CELUW last week (0303-0307)?
Weekly Report · 03/10 10:56
Weekly Report: what happened at CELUW last week (0224-0228)?
Weekly Report · 03/03 10:55
CELULARITY RECEIVES FDA TISSUE REFERENCE GROUP RECOMMENDATION LETTERS FOR ITS NATALIN AND ACELAGRAFT™ WOUND CARE PRODUCTS
Reuters · 02/25 13:00
CELULARITY INC - AGREEMENT TO INITIALLY FOCUS ON PRODUCTION OF BSB'S NOVEL TCR T CELL THERAPIES
Reuters · 02/24 13:00
Weekly Report: what happened at CELUW last week (0217-0221)?
Weekly Report · 02/24 10:55
CELULARITY INC - RWI EXTENDS MATURITY DATE OF $27 MILLION LOANS TO 2026
Reuters · 02/18 13:47
Weekly Report: what happened at CELUW last week (0210-0214)?
Weekly Report · 02/17 10:53
Weekly Report: what happened at CELUW last week (0203-0207)?
Weekly Report · 02/10 10:48
Weekly Report: what happened at CELUW last week (0127-0131)?
Weekly Report · 02/03 10:52
Weekly Report: what happened at CELUW last week (0120-0124)?
Weekly Report · 01/27 10:54
More
Webull provides a variety of real-time CELUW stock news. You can receive the latest news about Celularity Inc through multiple platforms. This information may help you make smarter investment decisions.
About CELUW
Celularity Inc. is a regenerative and cellular medicine company. It is developing and commercializing advanced biomaterial products and allogeneic, cryopreserved, placental-derived cell therapies, all derived from the postpartum placenta. Its therapeutic programs target aging-related diseases, including degenerative diseases, cancer, and immune disorders, using mesenchymal-like adherent stromal cells (MLASCs), T-cells engineered with CAR (CAR T-cells), and genetically modified and unmodified natural killer (NK) cells. It also develops, manufactures and commercializes advanced biomaterial products derived from structural tissue components of the postpartum placental tissues, including the umbilical cord. Its advanced biomaterials include Celularity Tendon Wrap, FUSE Bone Void Filler and Celularity Placental Matrix. Its advanced biomaterial products include Biovance and Interfyl products. Its platform is Celularity IMPACT (Immuno-Modulatory Placental-derived Allogeneic Cell Therapy).